Please use this identifier to cite or link to this item:
https://hdl.handle.net/1959.11/18562
Title: | Ethnopharmacology in Australia and Oceania | Contributor(s): | Jones, Graham L (author) ; Sadgrove, Nicholas (author) | Publication Date: | 2015 | Handle Link: | https://hdl.handle.net/1959.11/18562 | Abstract: | "Bioprospecting has gained much recent popular attention, particularly spurred by the apocryphal image of adventurous ethnobotanists penetrating at considerable peril the darkest recesses of the jungle at the behest of rich pharmaceutical firms". (Cox, 2008, p. 270) As Cox (2008) describes above, the discipline of bioprospecting often evokes images of brilliant but erratic ethnopharmacologists, as portrayed, for example, by Harrison Ford (Indiana Jones) and Sean Connery (Medicine Man); battling through thick jungles or mountainous terrain in search of an infallible panacea, used for millennia by indigenous people. However, by contrast with the Amazonian rainforest or the Himalayas, the Australian landmass is predominantly arid with deserts and temperate grasslands predominating. Such arid flat landscapes are where most of the recorded ethnopharmacologically significant Australian plants are found. Selective pressures in this geographically isolated arid land have nonetheless produced a higher proportion of total endemic flora, by comparison with the tropical or wet temperate islands of Oceania or indeed the rest of the world. Evolutionary biologists suggest that during prehistoric cycles of aridity, Australia's rich assortment of high secondary metabolite yielding flora emerged. This flora includes commercially important essential oil yielding species, such as 'Eucalyptus', 'Melaleuca' and 'Leptospermum' spp. Specific evolutionary advantages conferred on plants by characteristic secondary metabolites remain contentious. However, their contribution to the 'materia medica' of prehistoric Aboriginal people is beyond doubt. | Publication Type: | Book Chapter | Source of Publication: | Ethnopharmacology, p. 365-378 | Publisher: | John Wiley & Sons Ltd | Place of Publication: | Chichester, United Kingdom | ISBN: | 9781118930731 9781118930748 |
Fields of Research (FoR) 2008: | 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified 111701 Aboriginal and Torres Strait Islander Health 119999 Medical and Health Sciences not elsewhere classified |
Fields of Research (FoR) 2020: | 321499 Pharmacology and pharmaceutical sciences not elsewhere classified 450401 Aboriginal and Torres Strait Islander and disability 329999 Other biomedical and clinical sciences not elsewhere classified |
Socio-Economic Objective (SEO) 2008: | 950503 Understanding Australia's Past 920399 Indigenous Health not elsewhere classified |
Socio-Economic Objective (SEO) 2020: | 130703 Understanding Australia’s past | HERDC Category Description: | B1 Chapter in a Scholarly Book | Publisher/associated links: | http://trove.nla.gov.au/work/199558895 | Series Name: | ULLA Postgraduate Pharmacy Series | Editor: | Editor(s): Michael Heinrich and Anna K Jager |
---|---|
Appears in Collections: | Book Chapter |
Files in This Item:
File | Description | Size | Format |
---|
Page view(s)
1,336
checked on Nov 26, 2023
Download(s)
4
checked on Nov 26, 2023
Items in Research UNE are protected by copyright, with all rights reserved, unless otherwise indicated.